Developing better treatments in hepatocellular carcinoma
Author:
Publisher
Informa UK Limited
Subject
Gastroenterology,Hepatology
Link
http://www.tandfonline.com/doi/pdf/10.1586/egh.10.58
Reference76 articles.
1. Estimating the world cancer burden: Globocan 2000
2. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
3. Prospective validation of the Barcelona Clinic Liver Cancer staging system
4. Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1;International Journal of Toxicology;2023-06-18
2. Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells;Scientific Reports;2022-10-25
3. Overexpression of SLC40A1 inhibits the malignancy of hepatocellular carcinoma MHCC-97H cells by stimulation of autophagy;Biomedical Signal Processing and Control;2022-05
4. Effect of 5-azacytidine (5-aza) on UCP2 expression in human liver and colon cancer cells;International Journal of Medical Sciences;2021
5. Berberine Induces p53-Dependent Apoptosis through Inhibition of DNA Methyltransferase3b in Hep3B Cells;The Korean Journal of Clinical Laboratory Science;2020-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3